Eli Lilly to Acquire Centessa Pharmaceuticals for Initial $6.3 Billion

Eli Lilly announced its intention to acquire Centessa Pharmaceuticals for an initial $6.3 billion, a deal confirmed by recent reports, aiming to bolster its portfolio of sleep medicines and narcolepsy drugs.